Related Experiment Videos
New insulins and quality of life
1Department of Paediatrics, Second University of Naples, Naples, Italy. dario.iafusco@unina2.it
Insights
New insulin analogues offer flexible treatment options for children with diabetes, improving their quality of life. Personalized therapeutic plans and education are key to managing pediatric diabetes effectively.
Area of Science:
- Pediatrics
- Endocrinology
- Metabolic Disorders
Background:
- Pediatric diabetes management requires treatment customization to minimize life disruption.
- Maintaining a high quality of life, including social activities and sports, is crucial for diabetic children.
Purpose of the Study:
- To evaluate new insulin analogues for pediatric diabetes treatment.
- To assess the advantages and disadvantages of insulin analogues in meeting children's specific needs.
Main Methods:
- Review of characteristics of new short- and long-acting insulin analogues.
- Comparison of insulin analogues with traditional insulin formulations.
- Consideration of patient lifestyle, age, and social activities in treatment planning.
Main Results:
- New insulin formulations allow for highly personalized therapeutic plans.
- Short-acting insulin analogues can be administered immediately post-meal, aiding younger children and those with inconsistent lifestyles.
- Traditional insulins remain suitable for patients with predictable routines.
Conclusions:
- Flexible and individualized treatment plans are essential for enhancing the quality of life for children and adolescents with diabetes.
- Comprehensive patient and parent education is vital for improving treatment compliance and reducing anxiety.
Abstract:
Extreme customization of treatment is even more necessary when dealing with young diabetic patients as compared with adult patients. From diagnosis the pediatrician must introduce treatment in the less traumatic way possible so that the child does not perceive a derangement of his/her life. In order to preserve the quality of life the diabetic child must be able to attend birthday parties, participate in sports, and generally lead a full social life just like his/her friends. In the present paper we evaluate the characteristics of the new insulin analogues and their advantages and disadvantages with respect to the needs of patients. The wide spectrum of available insulin formulations including also the new short- and long- acting insulin analogues are of great help in conceiving a therapeutic plan closely adherent to the patient's needs. As an example, in children aged less than 5-6 years a short acting insulin may be injected immediatly after the meal. The same insulin may be useful in older patients with an incostant style of life due to social activities. On the other hand the "old" insulins may still be used for the therapeutic plan in patients with a more constant life style as to the physical exercise and intervals between the meals. In conclusion, the quality of life in the children and adolescents with diabetes may be accomplished with a flexible and personalized therapeutic plan and a great attention to the education. The latter is a very important tool for the compliance and the reduction of anxiety in patients and their parents.